Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin-based chemotherapy for primary colorectal cancer.
Camille JulioStephane BenoistMarc-Antoine AllardFrancis NavarroPatrick PessauxAntonio Sa CunhaAntoine Brouquetnull nullPublished in: Journal of surgical oncology (2022)
Liver resection provides a good outcome in patients with limited metachronous CLM after adjuvant oxaliplatin-based chemotherapy for CRC. The interest of preoperative chemotherapy is not obvious and should be tested in a prospective controlled study.